These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 37446204)

  • 1. Exploring the Role of Circulating Cell-Free RNA in the Development of Colorectal Cancer.
    Kan CM; Pei XM; Yeung MHY; Jin N; Ng SSM; Tsang HF; Cho WCS; Yim AK; Yu AC; Wong SCC
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy in colorectal cancer: Onward and upward.
    Torresan S; de Scordilli M; Bortolot M; Di Nardo P; Foltran L; Fumagalli A; Guardascione M; Ongaro E; Puglisi F
    Crit Rev Oncol Hematol; 2024 Feb; 194():104242. PubMed ID: 38128627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types.
    Ishiba T; Hoffmann AC; Usher J; Elshimali Y; Sturdevant T; Dang M; Jaimes Y; Tyagi R; Gonzales R; Grino M; Pinski JK; Barzi A; Raez LE; Eberhardt WE; Theegarten D; Lenz HJ; Uetake H; Danenberg PV; Danenberg K
    Biochem Biophys Res Commun; 2018 Jun; 500(3):621-625. PubMed ID: 29679564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy Number Variations as Determinants of Colorectal Tumor Progression in Liquid Biopsies.
    Debattista J; Grech L; Scerri C; Grech G
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-Educated Platelet RNA and Circulating Free RNA: Emerging Liquid Biopsy Markers for Different Tumor Types.
    Hu H; Song H; Han B; Zhao H; He J
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):80. PubMed ID: 38420812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios.
    Normanno N; Cervantes A; Ciardiello F; De Luca A; Pinto C
    Cancer Treat Rev; 2018 Nov; 70():1-8. PubMed ID: 30053724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value.
    Igder S; Zamani M; Fakher S; Siri M; Ashktorab H; Azarpira N; Mokarram P
    Dis Markers; 2024; 2024():9943412. PubMed ID: 38380073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review.
    Vymetalkova V; Cervena K; Bartu L; Vodicka P
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
    Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
    J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance.
    Stejskal P; Goodarzi H; Srovnal J; Hajdúch M; van 't Veer LJ; Magbanua MJM
    Mol Cancer; 2023 Jan; 22(1):15. PubMed ID: 36681803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA.
    Luo H; Wei W; Ye Z; Zheng J; Xu RH
    Trends Mol Med; 2021 May; 27(5):482-500. PubMed ID: 33500194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid biopsy in colorectal cancer.
    Najafi S; Majidpoor J; Mortezaee K
    Clin Chim Acta; 2024 Jan; 553():117674. PubMed ID: 38007059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer.
    Gianni C; Palleschi M; Merloni F; Di Menna G; Sirico M; Sarti S; Virga A; Ulivi P; Cecconetto L; Mariotti M; De Giorgi U
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes.
    Nimir M; Ma Y; Jeffreys SA; Opperman T; Young F; Khan T; Ding P; Chua W; Balakrishnar B; Cooper A; De Souza P; Becker TM
    Cells; 2019 Jul; 8(7):. PubMed ID: 31288377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of liquid biopsies in colorectal cancer.
    Wills B; Gorse E; Lee V
    Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements.
    Tuaeva NO; Falzone L; Porozov YB; Nosyrev AE; Trukhan VM; Kovatsi L; Spandidos DA; Drakoulis N; Kalogeraki A; Mamoulakis C; Tzanakakis G; Libra M; Tsatsakis A
    Cells; 2019 Oct; 8(10):. PubMed ID: 31615102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis.
    Wu J; Hu S; Zhang L; Xin J; Sun C; Wang L; Ding K; Wang B
    Theranostics; 2020; 10(10):4544-4556. PubMed ID: 32292514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating biomarkers for early detection and clinical management of colorectal cancer.
    Marcuello M; Vymetalkova V; Neves RPL; Duran-Sanchon S; Vedeld HM; Tham E; van Dalum G; Flügen G; Garcia-Barberan V; Fijneman RJ; Castells A; Vodicka P; Lind GE; Stoecklein NH; Heitzer E; Gironella M
    Mol Aspects Med; 2019 Oct; 69():107-122. PubMed ID: 31189073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.